Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Needham Maintains Buy on Surmodics, Lowers Price Target to $46

Needham analyst Mike Matson maintains Surmodics (NASDAQ:SRDX) with a Buy and lowers the price target from $58 to $46.
byBenzinga Newsdesk
April 28, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Needham analyst Mike Matson maintains Surmodics (NASDAQ:SRDX) with a Buy and lowers the price target from $58 to $46.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0